DC-AIM

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDC-AIM
Drug Alias Namealpha B-crystallin (Delta Crystallon)RDC-AIMDC-AIM
ClassificationSmall molecules
Mechanisms of ActionAlpha-Crystallin B Chain stimulants
TargetsAlpha-Crystallin B Chain
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructivealpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDelta Crystallon BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDelta Crystallon BV
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructivealpha 1-Antitrypsin Deficiency

Other Information

ATC CodeN/A
Related LinksN/A